120 related articles for article (PubMed ID: 910385)
1. The removal of uremic small and middle molecules and free amino acids by carbon hemoperfusion.
Oulès R; Asaba H; Neuhäuser M; Yahiel V; Gunnarsson B; Bergström J; Fürst P
Trans Am Soc Artif Intern Organs; 1977; 23():583-90. PubMed ID: 910385
[No Abstract] [Full Text] [Related]
2. [Retention of medium sized molecules in uremic serum].
Dall'aglio P; Buzio C; Cambi V; Arisi L; Migone L
Proc Eur Dial Transplant Assoc; 1972; 9():409-16. PubMed ID: 4668919
[No Abstract] [Full Text] [Related]
3. Hemoperfusion results in uremia.
Gelfand MC; Winchester JF
Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
[No Abstract] [Full Text] [Related]
4. Removal of endogenous middle molecules by hemoperfusion.
Asaba H; Bergström J; Fürst P; Gunnarsson B; Neuhauser M; Oulès R; Yahiel V
Artif Organs; 1979 May; 3(2):132-6. PubMed ID: 533396
[TBL] [Abstract][Full Text] [Related]
5. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
Marangoni R; Civardi F; Masi F; Avanzi C; Savino R; Manfredi A; Cimino R
Biomater Artif Cells Artif Organs; 1990; 18(4):541-8. PubMed ID: 2285819
[TBL] [Abstract][Full Text] [Related]
6. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
Bonomini V; Stefoni S; Casciani CU; Taccone Gallucci M; Albertazzi A; Cappelli P; Mioli V; Boggi R; Mastrangelo F; Rizzelli S
Contrib Nephrol; 1982; 29():133-42. PubMed ID: 7075212
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia.
Chang TM; Chirito E; Barre P; Cole C; Lister C; Resurreccion E
Artif Organs; 1979 May; 3(2):127-31. PubMed ID: 533395
[TBL] [Abstract][Full Text] [Related]
8. [Developmental tendencies of hemadsorption in uremia treatment].
Falkenhagen D; Holtz M; Ahrenholz P; Esther G; Osten B; Klinkmann H
Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 69-73. PubMed ID: 7467587
[TBL] [Abstract][Full Text] [Related]
9. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
[TBL] [Abstract][Full Text] [Related]
10. Solute, amino acid, and hormone changes with coated charcoal hemoperfusion in uremia.
Winchester JF; Ratcliffe JG; Carlyle E; Kennedy AC
Kidney Int; 1978 Jul; 14(1):74-81. PubMed ID: 682427
[TBL] [Abstract][Full Text] [Related]
11. Sorbent membrane dialysis in uremia.
Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
[TBL] [Abstract][Full Text] [Related]
12. The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.
Li J; Li D; Xu Y; Wang A; Xu C; Yu C
Ren Fail; 2015 Feb; 37(1):103-7. PubMed ID: 25421427
[TBL] [Abstract][Full Text] [Related]
13. Present and future uses of hemoperfusion with sorbents.
Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
[No Abstract] [Full Text] [Related]
14. Removal of uremic waste metabolites from the intestinal tract by encapsulated carbon and oxidized starch.
Sparks RE; Mason NS; Meier PM; Litt MH; Lindan O
Trans Am Soc Artif Intern Organs; 1971; 17():229-38. PubMed ID: 5158097
[No Abstract] [Full Text] [Related]
15. Assessments of clinical trials of charcoal hemoperfusion in uremic patients.
Chang TM
Clin Nephrol; 1979 Feb; 11(2):111-9. PubMed ID: 378489
[No Abstract] [Full Text] [Related]
16. Response to rapid removal of intermediate molecular weight solutes in uremic man.
Silverstein ME; Ford CA; Lysaght MJ; Henderson LW
Trans Am Soc Artif Intern Organs; 1974; 20 B():614-21. PubMed ID: 4450311
[No Abstract] [Full Text] [Related]
17. Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.
Coussa R; Martoni C; Bhathena J; Urbanska AM; Prakash S
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798777
[TBL] [Abstract][Full Text] [Related]
18. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
[No Abstract] [Full Text] [Related]
19. Hemoperfusion with uncoated amberlite XE-336 resin in normal and uremic dogs.
Rosenbaum JL; Kramer MS; Raja R
Nephron; 1978; 21(1):27-37. PubMed ID: 662054
[TBL] [Abstract][Full Text] [Related]
20. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
